Severely impaired terminal erythroid differentiation as an independent prognostic marker in myelodysplastic syndromes

Anemia is the defining feature in most patients with myelodysplastic syndromes (MDS), yet defects in erythropoiesis have not been well characterized. We examined freshly obtained bone marrow (BM) samples for stage-specific abnormalities during terminal erythroid differentiation (TED) from 221 sample...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Blood Adv
Autores principales: Ali, Abdullah Mahmood, Huang, Yumin, Pinheiro, Ronald Feitosa, Xue, Fumin, Hu, Jingping, Iverson, Nicholas, Hoehn, Daniela, Coutinho, Diego, Kayani, Jehanzeb, Chernak, Brian, Lane, Joseph, Hillyer, Christopher, Galili, Naomi, Jurcic, Joseph, Mohandas, Narla, An, Xiuli, Raza, Azra
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society of Hematology 2018
Materias:
Myeloid Neoplasia
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6020814/
https://ncbi.nlm.nih.gov/pubmed/29903708
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2018018440
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares